Young L, Duckett S, Dunn A
Department of Trauma and Orthopaedics, West Suffolk Hospital, Hardwick Lane, Bury St Edmunds, Suffolk, IP33 2QZ, UK.
J Bone Joint Surg Br. 2009 Feb;91(2):170-5. doi: 10.1302/0301-620X.91B2.20473.
We describe the survivorship of the Exeter femoral component in a District General Hospital. Between 1994 and 1996, 230 Exeter Universal cemented femoral components were implanted in 215 patients who were reviewed at a mean of 11.2 years (10 to 13). We used one acetabular implant, the Elite Ogee component, in 218 of the 230 hips. During the period of this study 76 patients (79 hips) died. Of the remaining 139 patients (151 hips), 121 were able to attend for radiological analysis at a minimum of ten years. One patient was lost to follow-up. No femoral component was revised for aseptic loosening. Three hips were revised for deep infection and six acetabular components required revision, four for loosening and two for recurrent dislocation. Taking the 'worst-case scenario' including the one patient lost to follow-up, the overall survival rate was 94.4% at 13 years. Our results confirm excellent medium-term results for the Exeter Universal femoral component, implanted in a general setting. The excellent survival of this femoral component, when used in combination with the Ogee acetabular component, suggests that this is a successful pairing.
我们描述了埃克塞特股骨假体在一家地区综合医院的生存率。1994年至1996年期间，230个埃克塞特通用骨水泥型股骨假体被植入215例患者体内，这些患者在平均11.2年（10至13年）时接受了复查。在230例髋关节中，我们在218例中使用了一种髋臼假体，即精英奥吉假体。在本研究期间，76例患者（79个髋关节）死亡。在其余139例患者（151个髋关节）中，121例能够在至少10年时接受放射学分析。1例患者失访。没有股骨假体因无菌性松动而翻修。3个髋关节因深部感染而翻修，6个髋臼假体需要翻修，4个因松动，2个因复发性脱位。采用“最坏情况设想”，包括1例失访患者，13年时的总体生存率为94.4%。我们的结果证实了在一般情况下植入的埃克塞特通用股骨假体具有优异的中期结果。这种股骨假体与奥吉髋臼假体联合使用时的优异生存率表明这是一种成功的配对。
